SAN DIEGO, July 05, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced new robust, real-world evidence confirming AVISE® testing enables ...

Los Angeles-based advisors Katrina Soelter and Leighann Miko on Thursday announced the launch of their RIA technology and services co-operative Avise Financial. The virtual platform seeks to ...

Because the AVISE Lupus Test can diagnose lupus earlier and in less severe cases than standard diagnostic laboratory tests (SDLTs), a new study finds it also results in significant savings in ...

What is the AVISE® CTD? AVISE® CTD is a blood test that can help doctors diagnose lupus and other autoimmune diseases — like rheumatoid arthritis, Sjögren's syndrome, or scleroderma. The test may be ...

Peloton cofounder, Graham Stanton, is shifting his focus from fitness nuts to financial wonks. Today Stanton and cofounder Edgar Thomas revealed their new accounting and bookkeeping company, Avise.

For more detailed information on Avise Financial ’s conduct, please visit Finra’s BrokerCheck, the SEC’s Investment Adviser Public Disclosure database, or your state’s regulatory agencies.

SAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the publication of their latest clinical utility study in ...

The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating superior laboratory testing for improved patient care CARLSBAD, ...